Clorox (CLX) Beats Big, Now What? Morgan Stanley Explains the Selloff, Reiterates Underweight
Tweet Send to a Friend
Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and $182.00 price target on Clorox (NYSE: CLX) with new guidance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
